A tool to help young cancer patients manage their symptoms
A Randomized Controlled Trial Using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
This study is testing a new computer tool to help young cancer patients better manage their symptoms during treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 126 (estimated) |
| Ages | 15 Years to 29 Years |
| Sex | All |
| Sponsor | Virginia Commonwealth University Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 5 sites (Kansas City, Missouri and 4 other locations) |
| Trial ID | NCT05958316 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the Computerized Symptom Assessment Tool (C-SCAT) in improving symptom self-management among adolescents and young adults diagnosed with cancer. Participants will be randomly assigned to either receive the C-SCAT intervention or usual care while undergoing cancer treatment. The study aims to assess changes in self-efficacy and self-management behaviors related to cancer symptoms over the course of treatment. A total of 126 participants will be involved, all within the first three months of their cancer diagnosis.
Who should consider this trial
Good fit: Ideal candidates are adolescents and young adults who have recently been diagnosed with cancer and are currently undergoing treatment.
Not a fit: Patients who are unable to complete study measures due to cognitive or physical limitations may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could empower young cancer patients to better manage their symptoms and improve their overall quality of life during treatment.
How similar studies have performed: Previous studies have shown promise in using technology for symptom management in cancer patients, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Has received at least 1 cycle of cancer treatment and is within 3 months of initial cancer diagnosis * Receiving regularly scheduled cancer treatment and will be receiving at least three more cycles * Reports at least 1 symptom related to cancer and/or its treatment * Able to speak, read, and write English as required for completion of the C-SCAT and study measures Exclusion Criteria: \- Cognitive and/or physical inability to complete study measures.
Where this trial is running
Kansas City, Missouri and 4 other locations
- Children's Mercy Hospital — Kansas City, Missouri, United States (Recruiting)
- University of Utah Huntsman Cancer Institute (HCI) — Salt Lake City, Utah, United States (Recruiting)
- University of Utah Primary Children's Hospital — Salt Lake City, Utah, United States (Recruiting)
- Virginia Commonwealth University — Richmond, Virginia, United States (Recruiting)
- Seattle Children's Hospital @ University of Washington — Seattle, Washington, United States (Active_not_recruiting)
Study contacts
- Principal investigator: Ronald Elswick, PhD — Virginia Commonwealth University
- Study coordinator: Grace Hodges
- Email: hodgesg@vcu.edu
- Phone: 804-828-8917
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.